JP Stock MarketDetailed Quotes

4553 TOWA Pharmaceutical

Watchlist
  • 2915
  • +115+4.11%
20min DelayNot Open Dec 20 15:30 JST
150.17BMarket Cap8.87P/E (Static)

TOWA Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(FY)Mar 31, 2023
(FY)Mar 31, 2022
(FY)Mar 31, 2021
(FY)Mar 31, 2020
(FY)Mar 31, 2019
(FY)Mar 31, 2018
(FY)Mar 31, 2017
(FY)Mar 31, 2016
Operating cash flow (Indirect Method)
Cash from operating activities
1.66B
11.26%10.09B
-66.15%9.07B
49.03%26.78B
-30.34%17.97B
13.40%25.8B
10.30%22.75B
86.76%20.63B
22.17%11.04B
-17.34%9.04B
Net profit before non-cash adjustment
--8.58B
431.14%24.46B
-79.30%4.61B
18.78%22.25B
-9.57%18.73B
9.65%20.71B
92.07%18.89B
35.87%9.83B
-26.92%7.24B
-34.87%9.9B
Total adjustment of non-cash items
---5.5B
-0.02%18.2B
138.44%18.21B
-29.32%7.64B
122.47%10.8B
-10.39%4.86B
-56.08%5.42B
48.55%12.34B
8.96%8.31B
113.74%7.62B
-Depreciation and amortization
--4.74B
-7.84%17.89B
77.19%19.41B
5.07%10.95B
25.83%10.43B
-0.66%8.29B
2.04%8.34B
2.42%8.17B
8.88%7.98B
28.04%7.33B
-Reversal of impairment losses recognized in profit and loss
----
----
----
--25M
----
----
-90.28%175M
--1.8B
----
----
-Disposal profit
---2.22B
-402.51%-5.79B
164.11%1.92B
-231.35%-2.99B
162.05%2.27B
-229.29%-3.67B
-179.05%-1.11B
102.30%1.41B
-72.42%696M
187.34%2.52B
-Other non-cash items
---8.01B
295.99%6.11B
-775.56%-3.12B
81.22%-356M
-903.39%-1.9B
111.90%236M
-307.43%-1.98B
357.68%956M
83.37%-371M
-404.78%-2.23B
Changes in working capital
---1.43B
-136.95%-32.57B
-343.17%-13.75B
73.16%-3.1B
-5,060.94%-11.56B
115.00%233M
-0.45%-1.55B
65.61%-1.55B
47.01%-4.5B
-8.28%-8.49B
-Change in receivables
--525M
-875.06%-15.52B
-461.00%-1.59B
109.71%441M
-263.69%-4.54B
166.84%2.78B
2.05%-4.15B
-907.13%-4.24B
86.57%-421M
0.95%-3.13B
-Change in inventory
---2.81B
66.00%-6.29B
-132.65%-18.5B
18.10%-7.95B
-125.69%-9.71B
-166.15%-4.3B
-150.63%-1.62B
230.87%3.19B
64.72%-2.44B
7.86%-6.91B
-Change in payables
----
-260.34%-10.51B
78.34%6.55B
49.94%3.68B
34.23%2.45B
-60.81%1.83B
581.80%4.66B
29.47%-967M
-188.85%-1.37B
-44.91%1.54B
-Provision for loans, leases and other losses
--185M
-5.83%-254M
-133.10%-240M
193.52%725M
463.24%247M
84.65%-68M
-194.46%-443M
276.98%469M
-1,494.74%-265M
-36.67%19M
-Changes in other current assets
--672M
--0
285.71%27M
216.67%7M
---6M
----
----
----
----
----
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
-326M
-54.26%-941M
-169.91%-610M
-31.40%-226M
-32.31%-172M
12.16%-130M
8.07%-148M
1.23%-161M
2.40%-163M
-24.63%-167M
Interest received (cash flow from operating activities)
63M
333.33%104M
166.67%24M
-43.75%9M
-78.95%16M
80.95%76M
-19.23%42M
126.09%52M
-77.00%23M
-13.79%100M
Tax refund paid
-7.3B
72.00%-1.76B
-32.40%-6.29B
23.82%-4.75B
9.31%-6.23B
-62.59%-6.87B
-182.49%-4.23B
-19.01%-1.5B
76.58%-1.26B
-81.72%-5.37B
Other operating cash inflow (outflow)
15M
106.88%722M
12.22%349M
-26.65%311M
46.71%424M
-50.43%289M
178.95%583M
-61.86%209M
331.50%548M
73.97%127M
Operating cash flow
---5.89B
222.80%8.21B
-88.50%2.54B
84.29%22.13B
-37.34%12.01B
0.85%19.16B
-1.19%19B
88.62%19.23B
173.18%10.2B
-53.56%3.73B
Investing cash flow
Capital expenditures
---1.62B
----
----
----
----
----
----
----
----
----
Net PPE purchase and sale
----
-32.84%-37.85B
-156.73%-28.49B
-21.50%-11.1B
-100.79%-9.13B
59.04%-4.55B
14.26%-11.11B
34.60%-12.95B
-46.14%-19.81B
-1.75%-13.55B
Net intangibles purchase and sale
----
38.77%-1.06B
26.77%-1.72B
-369.66%-2.35B
-314.05%-501M
42.65%-121M
76.48%-211M
-31.91%-897M
-20.78%-680M
-46.23%-563M
Net business purchase and sale
----
---1.57B
--0
-4,978.86%-45.41B
97.63%-894M
-18,117.39%-37.71B
---207M
----
----
----
Net investment product transactions
----
81.27%-50M
-1,670.59%-267M
--17M
--0
-43.30%4.86B
257.86%8.57B
-287.03%-5.43B
76.62%-1.4B
-220.00%-6B
Advance cash and loans provided to other parties
----
----
----
---670M
----
-85.22%-2.13B
-24.46%-1.15B
---924M
----
----
Repayment of advance payments to other parties and cash income from loans
----
----
----
----
--130M
----
----
----
----
----
Net changes in other investments
--10M
-33.84%131M
190.00%198M
-116.94%-220M
1,091.74%1.3B
0.00%109M
-2.68%109M
135.33%112M
-129.24%-317M
128.21%1.08B
Investing cash flow
---1.61B
-33.38%-40.39B
49.30%-30.28B
-556.36%-59.73B
76.99%-9.1B
-890.01%-39.54B
80.12%-3.99B
9.52%-20.09B
-16.68%-22.21B
-131.25%-19.03B
Financing cash flow
Net issuance payments of debt
--10.54B
84.65%38.56B
-57.48%20.88B
1,861.42%49.11B
-81.86%2.5B
1,738.08%13.8B
-87.94%751M
324.61%6.23B
-95.78%1.47B
2,188.94%34.77B
Net common stock issuance
----
--0
--0
--21M
--0
--12M
--0
----
--0
---5.04B
Increase or decrease of lease financing
----
-52.05%-222M
7.59%-146M
-26.40%-158M
---125M
----
----
----
----
----
Cash dividends paid
---1.41B
4.77%-2.95B
-28.58%-3.1B
-11.31%-2.41B
-4.79%-2.17B
-32.58%-2.07B
-0.13%-1.56B
0.06%-1.56B
11.23%-1.56B
-37.65%-1.76B
Net other fund-raising expenses
--2.27B
113.46%21M
-500.00%-156M
10.34%-26M
-2,800.00%-29M
0.00%-1M
50.00%-1M
-100.00%-2M
50.00%-1M
0.00%-2M
Financing cash flow
--11.4B
102.55%35.41B
-62.44%17.48B
25,193.48%46.54B
-98.43%184M
1,552.16%11.75B
-117.32%-809M
5,176.09%4.67B
-100.33%-92M
11,652.10%27.97B
Net cash flow
Beginning cash position
--29.65B
-26.11%24.26B
43.27%32.83B
22.45%22.92B
-29.79%18.71B
131.54%26.65B
61.85%11.51B
-61.61%7.11B
255.72%18.53B
11.40%5.21B
Current changes in cash
--3.9B
131.44%3.23B
-214.75%-10.26B
189.13%8.94B
135.83%3.09B
-160.77%-8.63B
272.97%14.2B
131.46%3.81B
-195.52%-12.1B
28,055.56%12.67B
Effect of exchange rate changes
--1.25B
28.61%2.17B
72.82%1.69B
28.12%975M
10.45%761M
-26.94%689M
59.56%943M
-14.22%591M
6.33%689M
33.06%648M
Cash adjustments other than cash changes
--213M
0.00%1M
--1M
----
34,800.00%349M
200.00%1M
-200.00%-1M
--1M
----
----
End cash Position
--35.02B
22.23%29.65B
-26.11%24.26B
43.27%32.83B
22.45%22.92B
-29.79%18.71B
131.54%26.65B
61.85%11.51B
-61.61%7.11B
255.72%18.53B
Free cash flow
---7.52B
-11.42%-31.11B
-426.49%-27.93B
301.74%8.55B
-85.31%2.13B
89.51%14.49B
98.29%7.65B
135.15%3.86B
-5.66%-10.97B
-83.19%-10.39B
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Jun 30, 2024(FY)Mar 31, 2024(FY)Mar 31, 2023(FY)Mar 31, 2022(FY)Mar 31, 2021(FY)Mar 31, 2020(FY)Mar 31, 2019(FY)Mar 31, 2018(FY)Mar 31, 2017(FY)Mar 31, 2016
Operating cash flow (Indirect Method)
Cash from operating activities 1.66B11.26%10.09B-66.15%9.07B49.03%26.78B-30.34%17.97B13.40%25.8B10.30%22.75B86.76%20.63B22.17%11.04B-17.34%9.04B
Net profit before non-cash adjustment --8.58B431.14%24.46B-79.30%4.61B18.78%22.25B-9.57%18.73B9.65%20.71B92.07%18.89B35.87%9.83B-26.92%7.24B-34.87%9.9B
Total adjustment of non-cash items ---5.5B-0.02%18.2B138.44%18.21B-29.32%7.64B122.47%10.8B-10.39%4.86B-56.08%5.42B48.55%12.34B8.96%8.31B113.74%7.62B
-Depreciation and amortization --4.74B-7.84%17.89B77.19%19.41B5.07%10.95B25.83%10.43B-0.66%8.29B2.04%8.34B2.42%8.17B8.88%7.98B28.04%7.33B
-Reversal of impairment losses recognized in profit and loss --------------25M---------90.28%175M--1.8B--------
-Disposal profit ---2.22B-402.51%-5.79B164.11%1.92B-231.35%-2.99B162.05%2.27B-229.29%-3.67B-179.05%-1.11B102.30%1.41B-72.42%696M187.34%2.52B
-Other non-cash items ---8.01B295.99%6.11B-775.56%-3.12B81.22%-356M-903.39%-1.9B111.90%236M-307.43%-1.98B357.68%956M83.37%-371M-404.78%-2.23B
Changes in working capital ---1.43B-136.95%-32.57B-343.17%-13.75B73.16%-3.1B-5,060.94%-11.56B115.00%233M-0.45%-1.55B65.61%-1.55B47.01%-4.5B-8.28%-8.49B
-Change in receivables --525M-875.06%-15.52B-461.00%-1.59B109.71%441M-263.69%-4.54B166.84%2.78B2.05%-4.15B-907.13%-4.24B86.57%-421M0.95%-3.13B
-Change in inventory ---2.81B66.00%-6.29B-132.65%-18.5B18.10%-7.95B-125.69%-9.71B-166.15%-4.3B-150.63%-1.62B230.87%3.19B64.72%-2.44B7.86%-6.91B
-Change in payables -----260.34%-10.51B78.34%6.55B49.94%3.68B34.23%2.45B-60.81%1.83B581.80%4.66B29.47%-967M-188.85%-1.37B-44.91%1.54B
-Provision for loans, leases and other losses --185M-5.83%-254M-133.10%-240M193.52%725M463.24%247M84.65%-68M-194.46%-443M276.98%469M-1,494.74%-265M-36.67%19M
-Changes in other current assets --672M--0285.71%27M216.67%7M---6M--------------------
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities) -326M-54.26%-941M-169.91%-610M-31.40%-226M-32.31%-172M12.16%-130M8.07%-148M1.23%-161M2.40%-163M-24.63%-167M
Interest received (cash flow from operating activities) 63M333.33%104M166.67%24M-43.75%9M-78.95%16M80.95%76M-19.23%42M126.09%52M-77.00%23M-13.79%100M
Tax refund paid -7.3B72.00%-1.76B-32.40%-6.29B23.82%-4.75B9.31%-6.23B-62.59%-6.87B-182.49%-4.23B-19.01%-1.5B76.58%-1.26B-81.72%-5.37B
Other operating cash inflow (outflow) 15M106.88%722M12.22%349M-26.65%311M46.71%424M-50.43%289M178.95%583M-61.86%209M331.50%548M73.97%127M
Operating cash flow ---5.89B222.80%8.21B-88.50%2.54B84.29%22.13B-37.34%12.01B0.85%19.16B-1.19%19B88.62%19.23B173.18%10.2B-53.56%3.73B
Investing cash flow
Capital expenditures ---1.62B------------------------------------
Net PPE purchase and sale -----32.84%-37.85B-156.73%-28.49B-21.50%-11.1B-100.79%-9.13B59.04%-4.55B14.26%-11.11B34.60%-12.95B-46.14%-19.81B-1.75%-13.55B
Net intangibles purchase and sale ----38.77%-1.06B26.77%-1.72B-369.66%-2.35B-314.05%-501M42.65%-121M76.48%-211M-31.91%-897M-20.78%-680M-46.23%-563M
Net business purchase and sale -------1.57B--0-4,978.86%-45.41B97.63%-894M-18,117.39%-37.71B---207M------------
Net investment product transactions ----81.27%-50M-1,670.59%-267M--17M--0-43.30%4.86B257.86%8.57B-287.03%-5.43B76.62%-1.4B-220.00%-6B
Advance cash and loans provided to other parties ---------------670M-----85.22%-2.13B-24.46%-1.15B---924M--------
Repayment of advance payments to other parties and cash income from loans ------------------130M--------------------
Net changes in other investments --10M-33.84%131M190.00%198M-116.94%-220M1,091.74%1.3B0.00%109M-2.68%109M135.33%112M-129.24%-317M128.21%1.08B
Investing cash flow ---1.61B-33.38%-40.39B49.30%-30.28B-556.36%-59.73B76.99%-9.1B-890.01%-39.54B80.12%-3.99B9.52%-20.09B-16.68%-22.21B-131.25%-19.03B
Financing cash flow
Net issuance payments of debt --10.54B84.65%38.56B-57.48%20.88B1,861.42%49.11B-81.86%2.5B1,738.08%13.8B-87.94%751M324.61%6.23B-95.78%1.47B2,188.94%34.77B
Net common stock issuance ------0--0--21M--0--12M--0------0---5.04B
Increase or decrease of lease financing -----52.05%-222M7.59%-146M-26.40%-158M---125M--------------------
Cash dividends paid ---1.41B4.77%-2.95B-28.58%-3.1B-11.31%-2.41B-4.79%-2.17B-32.58%-2.07B-0.13%-1.56B0.06%-1.56B11.23%-1.56B-37.65%-1.76B
Net other fund-raising expenses --2.27B113.46%21M-500.00%-156M10.34%-26M-2,800.00%-29M0.00%-1M50.00%-1M-100.00%-2M50.00%-1M0.00%-2M
Financing cash flow --11.4B102.55%35.41B-62.44%17.48B25,193.48%46.54B-98.43%184M1,552.16%11.75B-117.32%-809M5,176.09%4.67B-100.33%-92M11,652.10%27.97B
Net cash flow
Beginning cash position --29.65B-26.11%24.26B43.27%32.83B22.45%22.92B-29.79%18.71B131.54%26.65B61.85%11.51B-61.61%7.11B255.72%18.53B11.40%5.21B
Current changes in cash --3.9B131.44%3.23B-214.75%-10.26B189.13%8.94B135.83%3.09B-160.77%-8.63B272.97%14.2B131.46%3.81B-195.52%-12.1B28,055.56%12.67B
Effect of exchange rate changes --1.25B28.61%2.17B72.82%1.69B28.12%975M10.45%761M-26.94%689M59.56%943M-14.22%591M6.33%689M33.06%648M
Cash adjustments other than cash changes --213M0.00%1M--1M----34,800.00%349M200.00%1M-200.00%-1M--1M--------
End cash Position --35.02B22.23%29.65B-26.11%24.26B43.27%32.83B22.45%22.92B-29.79%18.71B131.54%26.65B61.85%11.51B-61.61%7.11B255.72%18.53B
Free cash flow ---7.52B-11.42%-31.11B-426.49%-27.93B301.74%8.55B-85.31%2.13B89.51%14.49B98.29%7.65B135.15%3.86B-5.66%-10.97B-83.19%-10.39B
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Wintest
6721
127 +30.93%
Showcase
3909
349 +29.74%
Beauty Kadan Holdings
3041
417 +23.74%
Cybozu
4776
2644 +23.32%
KODAMA CHEMICAL INDUSTRY
4222
440 +22.22%

See the daily top gainer.